Screening for aminoacidurias in psychiatric inpatients.
D000342:Affective Symptoms / Q000209:etiology; D000592:Amino Acid Metabolism, Inborn Errors / Q000150:complications / Q000175:diagnosis*; D001925:Brain Damage, Chronic / Q000209:etiology; D003863:Depression / Q000188:drug therapy; D004357:Drug Synergism; D006250:Hartnup Disease / Q000150:complications; D006712:Homocystinuria / Q000150:complications; D006778:Hospitals, Psychiatric; D006801:Humans; D008607:Intellectual Disability / Q000209:etiology; D008403:Mass Screening; D008404:Massachusetts; D001523:Mental Disorders / Q000209:etiology*; D008715:Methionine / Q000008:administration & dosage / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage; D009497:Neurotic Disorders / Q000209:etiology; D010554:Personality Disorders / Q000209:etiology; D010661:Phenylketonurias / Q000150:complications; D012559:Schizophrenia / Q000209:etiology / Q000378:metabolism; D019966:Substance-Related Disorders / Q000209:etiology; D014364:Tryptophan / Q000008:administration & dosage / Q000378:metabolism
D008996:Monoamine Oxidase Inhibitors; D014364:Tryptophan; D008715:Methionine